These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36970507)

  • 1. Podoplanin: A potential therapeutic target for thrombotic diseases.
    Huang Y; Lu M; Wang Y; Zhang C; Cao Y; Zhang X
    Front Neurol; 2023; 14():1118843. PubMed ID: 36970507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin: Its roles and functions in neurological diseases and brain cancers.
    Wang Y; Peng D; Huang Y; Cao Y; Li H; Zhang X
    Front Pharmacol; 2022; 13():964973. PubMed ID: 36176432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology.
    Suzuki-Inoue K; Tsukiji N
    Curr Opin Hematol; 2024 May; 31(3):130-139. PubMed ID: 38359177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity.
    Bianchi R; Fischer E; Yuen D; Ernst E; Ochsenbein AM; Chen L; Otto VI; Detmar M
    J Biol Chem; 2014 Jul; 289(30):21016-27. PubMed ID: 24907275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet CLEC-2: Roles Beyond Hemostasis.
    Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
    Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physiological and pathophysiological roles of platelet CLEC-2.
    Navarro-Núñez L; Langan SA; Nash GB; Watson SP
    Thromb Haemost; 2013 Jun; 109(6):991-8. PubMed ID: 23572154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-type lectin-like receptor 2: roles and drug target.
    Sun L; Wang Z; Liu Z; Mu G; Cui Y; Xiang Q
    Thromb J; 2024 Mar; 22(1):27. PubMed ID: 38504248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
    Suzuki Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer.
    Sasano T; Gonzalez-Delgado R; Muñoz NM; Carlos-Alcade W; Cho MS; Sheth RA; Sood AK; Afshar-Kharghan V
    J Thromb Haemost; 2022 Jan; 20(1):104-114. PubMed ID: 34608736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Podoplanin in Malignant Progression of Tumor.
    Suzuki H; Kaneko MK; Kato Y
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin in Inflammation and Cancer.
    Quintanilla M; Montero-Montero L; Renart J; Martín-Villar E
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New horizon in platelet function: with special reference to a recently-found molecule, CLEC-2.
    Ozaki Y; Tamura S; Suzuki-Inoue K
    Thromb J; 2016; 14(Suppl 1):27. PubMed ID: 27766053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Podoplanin-Positive Cells in Cardiac Fibrosis and Angiogenesis After Ischemia.
    Cimini M; Kishore R
    Front Physiol; 2021; 12():667278. PubMed ID: 33912076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podoplanin: emerging functions in development, the immune system, and cancer.
    Astarita JL; Acton SE; Turley SJ
    Front Immunol; 2012; 3():283. PubMed ID: 22988448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin and CLEC-2 levels in patients with COVID-19.
    Borba-Junior IT; Lima F; Vitoria Rodrigues Oliveira DS; Peachazepi Moraes CR; Annichino-Bizzacchi JM; Bombassaro B; Palma AC; Maranhao Costa FT; Moretti ML; Mansour E; Velloso LA; Orsi FA; De Paula EV
    Res Pract Thromb Haemost; 2023 Jun; 7(5):100282. PubMed ID: 37361399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of CLEC-2 and Its Ligands in Thromboinflammation.
    Meng D; Luo M; Liu B
    Front Immunol; 2021; 12():688643. PubMed ID: 34177942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application].
    Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis.
    Hur J; Jang JH; Oh IY; Choi JI; Yun JY; Kim J; Choi YE; Ko SB; Kang JA; Kang J; Lee SE; Lee H; Park YB; Kim HS
    Mol Ther; 2014 Aug; 22(8):1518-1529. PubMed ID: 24736277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome.
    Ji Y; Wang YL; Xu F; Jia XB; Mu SH; Lyu HY; Yuan XY; Na SP; Bao YS
    Clin Appl Thromb Hemost; 2022; 28():10760296221108967. PubMed ID: 35862263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.